Cardiac Rhythm Management System Market 2022 Research Report Analysis, Growth Prospects, Business Overview and Growth Rate
Global
Cardiac
Rhythm Management System Market,
on the basis of application, is segmented into tachyarrhythmia, heart failure,
bradyarrhythmia and so on. Cardiac rhythm management implies knowledge,
training, and skills needed for the selection & placement of pacemakers and
cardiac resynchronization therapy (CRT) devices. Cardiac rhythm management is
also known as cardiac arrhythmia, cardiac dysrhythmia or irregular heartbeat.
Cardiac rhythm management system informs about the irregularity of patients’
heartbeat; i.e. whether it’s too fast or too slow. When heartbeat is above 100
beats per minute; it is too fast. It is termed as “tachycardia” and heartbeat
below 60 beats per minute that is too slow is termed as bradycardia.
In
cardiac rhythm management, CRM devices play an important role in the treatment
of serious cardiac disorders such as heart failure, atrial flutter, indications
of heart attack, atrial fibrillation, lack of oxygen supply to cardiac muscles,
coronary ischemia, certain genetics errors, and effects of drugs.
View Full Report
with TOC @ https://www.millioninsights.com/industry-reports/cardiac-rhythm-management-system-market
The
major factors that play an important role in the cardiac rhythm management
system market are increasing use of mobile cardiac telemetry, growing incidence
of cardiovascular disorders, growth in home care & private institutional
nursing, limited remuneration for remote cardiac monitoring devices and lack of
skilled healthcare professionals with expertise in cardiac monitoring and
electrocardiography.
The
key target audiences of the cardiac rhythm management system market are
physicians, diagnostic centers, health insurance players, healthcare service
providers, monitoring services providers, cardiac monitoring, and cardiac
rhythm management device manufacturers. Cardiac rhythm management system market
is segmented on the basis of product, application, end user, and geography.
Based
on product, the cardiac rhythm management system market is segmented into
cardiac resynchronization therapy (CRT) devices, HF management system,
pacemakers, implantable cardiac defibrillator (ICD), and so on. The segment
“cardiac resynchronization therapy (CRT) devices” is further classified as
CRT-P (CRT with pacemaker function) and CRT-D (CRT with pacemaker and ICD
function) and so on; whereas the segment “pacemaker” is further classified as
implantable pacemakers, external pacemakers, and so on.
Based
on end user, the cardiac rhythm management system market is segmented into home
settings, hospitals & clinics, ambulatory surgical centers (ASCs), and so
on.
Based
on geography, the cardiac rhythm management system market is segmented into
North America, Asia Pacific, Europe, Latin America, and Middle East &
Africa. Asia Pacific holds the largest large share in the cardiac rhythm
management system market due to lower cost of devices, growing disposable
income, and increasing patient awareness levels. Also, North America is
expected to grow at the highest CAGR rate in the years to come; followed by
Europe.
Key
players operating in the cardiac rhythm management system industry are Boston
Scientific, Cardiac Science, Philips Healthcare, General Electric (GE)
Healthcare Company, Medtronic, Schiller, Sorin S.p.A., St. Jude Medical Inc.,
Biotronik SE & Co. KG, Mortara Instrument, Koninklijke Philips N.V., and
Biotronik.
Request Sample
Copy of This Report @ https://www.millioninsights.com/industry-reports/cardiac-rhythm-management-system-market/request-sample
Comments
Post a Comment